PFM Health Sciences, LP 13D and 13G filings for Axsome Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | PFM Health Sciences, LP | 1,391,831 3.200% | -767,902 (-35.56%) | Filing |
| 2022-10-24 4:01 pm Purchase | 2022-10-14 | 13G | Axsome Therapeutics, Inc. AXSM | PFM Health Sciences, LP | 2,159,733 5.400% | 2,159,733 (New Position) | Filing |